2011”N1ŒŽ11“ú
XV |
Sato N, Yamabuki T, Takano A, Koinuma J, Aragaki M, Masuda K, Ishikawa N, Kohno N, Ito H, Miyamoto M, Nakayama H, Miyagi Y, Tsuchiya E, Kondo S, Nakamura Y, Daigo Y* |
Wnt inhibitor Dickkopf-1 as a target for passive cancer immunotherapy. ** |
Cancer Res. 2010;70:5326-36. @ PMID: 20551066 |
RDickkopf-1 (DKK1)R‘Ì‚ÍŠà×–E‚©‚番”傳‚ꂽDKK1ƒ^ƒ“ƒpƒN‹@”\‚𒆘a‚µ‚ÄŠà×–E‚ɃAƒ|ƒg[ƒVƒX‚ð—U“±‚·‚é |
|
Nguyen MH, Koinuma J, Ueda K, Ito T, Tsuchiya E, Nakamura Y, Daigo Y* |
Phosphorylation and activation of cell division cycle associated 5 by mitogen-activated protein kinase play a crucial role in human lung carcinogenesis. *** |
Cancer Res. 2010;70:5337-47. @ PMID: 20551060 |
CDCA5ƒ^ƒ“ƒpƒN—R—ˆ‚Ì×–E–Œ“§‰ß«ƒyƒvƒ`ƒh‚ÍERKƒLƒi[ƒ[‚É‚æ‚éCDCA5‚̃Šƒ“Ž_‰»‚ð‘I‘ð“I‚É‘jŠQ‚µŠà×–E‚Ì‘B‚ð—}§‚·‚é |
|
i*Corresponding authorA**ƒI[ƒ_[ƒƒCƒhˆã—ÃŽÀŒ»‰»ƒvƒƒWƒFƒNƒgiŽ ‰êˆã‘å•a‰@‚ðŠÜ‚Þ12ˆã—Ë@ŠÖjŽŽ—¿‚ð—p‚¢‚½Œ¤‹†A***•Ä‘ŠàŠw‰ï(AACR) 100th Annual Meeting, Scholar-In-Training AwardsŽóÜŒ¤‹†j |
y—vŽ|z
ˆ««Žîᇂɑ΂·‚éV‹K‚ÌR‘̈ã–ò‚ƃyƒvƒ`ƒhˆã–ò‚ÌŠJ”‚ÉŒü‚¯‚½Œ¤‹†FRDKK1R‘Ì‚Æ×–E–Œ“§‰ß«CDCA5—R—ˆƒyƒvƒ`ƒh‚ÌRŽîᇌø‰Ê‚ðŒŸØ
R‘̈ã–ò
@Šà×–E“ÁˆÙ“I‚É”Œ»‚·‚é×–E–Œƒ^ƒ“ƒpƒNAŠà×–E‘BˆöŽq‚Æ‚µ‚Ä“‚•ª”åƒ^ƒ“ƒpƒN‚ÍR‘̈ã–ò‚Ì—L—p‚ÈŽ¡—ÕW“I•ªŽq‚Æl‚¦‚ç‚ê‚éB‰äX‚Í•ª”åƒ^ƒ“ƒpƒNDKK1‚ª”xŠàAH“¹ŠàAˆÝŠàAŠÌŠàA’_ŠÇŠàAäXŠàA“ûŠàAŽq‹{ŒzŠà‘gD‚Å‚ƒŒƒxƒ‹‚É”Œ»‚µAŠ³ŽÒŒŒ´’†‚Å‚’l‚ðŽ¦‚µ‚ÄŒŒ´f’fƒoƒCƒIƒ}[ƒJ[‚Æ‚µ‚Ä—L—p‚Å‚ ‚邱‚Æ‚ðŽ¦‚µ‚½BRDKK1R‘Ì‚ð”|—{‰t’†‚É“Y‰Á‚·‚邱‚Æ‚É‚æ‚èŠà×–E‚̃Aƒ|ƒg[ƒVƒX‚ª—U“±‚³‚ê‚邱‚ÆA‚Ü‚½ƒ}ƒEƒX‚ɈÚA‚µ‚½Šà×–E‚ÍRDKK1R‘Ì‚Ì‘Sg“Š—^‚É‚æ‚è‘B‚ª—}§‚³‚ê‚邱‚Æ‚©‚çADKK1‚ð‰î‚µ‚½ƒVƒOƒiƒ‹“`’BŒo˜H‚ÍŠà‚ÌR‘̗Ö@‚Ì—L–]‚È•W“I‚Æl‚¦‚ç‚ê‚éB
ƒyƒvƒ`ƒhˆã–ò
@ ”xŠà‚̃Qƒmƒ€ƒƒCƒh‚Ȉâ“`Žq”Œ»î•ñ‰ðÍ‚É‚æ‚莡—ÕW“I•ªŽq‚Æ‚È‚éoncoprotein‚Æ‚µ‚ÄCDCA5 (cell-division-associated 5)‚𓯒肵A262—á‚©‚ç‚È‚é”xŠà‘gDƒ}ƒCƒNƒƒAƒŒƒC‰ðÍ‚É‚æ‚èCDCA5‚ª‚ƒŒƒxƒ‹‚É”Œ»‚µ‚Ä‚¢‚éÇ—á‚Í—LˆÓ‚É—\Œã•s—Ç‚Å‚ ‚邱‚Æ‚ðŽ¦‚µ‚½B‚Ü‚½CDCA5‚ÍERK (extracellular signal-regulated kinase)‚É‚æ‚èASerine 209‚ŃŠƒ“Ž_‰»‚ðŽó‚¯‚ÄAŠà×–E‚Ì‘B‚ÉŠÖ‚í‚邱‚Ƃ𖾂炩‚É‚µ‚½B‚»‚±‚ÅCDCA5‚ÌSerine 209‚ðŠÜ‚Þ20ƒAƒ~ƒmŽ_‚Æ11ŒÂ‚ÌArgininei–Œ“§‰ß«”z—ñj‚ð—Z‡‚µ‚½×–E–Œ“§‰ß«ƒyƒvƒ`ƒh‚ð‡¬‚µ‚Ä”xŠà×–EŠ”‚Ì”|—{‰t’†‚É“Y‰Á‚µ‚½‚Æ‚±‚ëAERK‚É‚æ‚éCDCA5‚Ì‘I‘ð“IƒŠƒ“Ž_‰»‚ª‹£‡“I‚É‘jŠQ‚³‚êAŠà×–E‚Ì‘B‚ª—}§‚³‚ꂽBˆÈã‚ÌŒ‹‰Ê‚æ‚èACDCA5‚ÆERK‚Ìy‘fŠîŽ¿”½‰ž‚ð‘I‘ð“I‚É‘jŠQ‚·‚éƒyƒvƒ`ƒhˆã–ò‚â’ᕪŽq‰»‡•¨‚ÍA•›ì—p‚Ì‚È‚¢—L–]‚È”xŠàŽ¡—Öò‚Æ‚È‚é‰Â”\«‚ªŽ¦´‚³‚ꂽB
•¶Ó@‘‡‚ª‚ñŽ¡—ÊwuÀEŽîᇓà‰È@‘çŒí@–푾˜Y |